IntelGenx Technologies Corp (OTCMKTS:IGXT) Is Today’s Pharma Focus IntelGenx Technologies Inc (OTCMKTS:IGXT) has quickly run up the charts after the company sold its royalty on future sales of Forfivo XL® to SWK Holdings Corporation (OTCMKTS:SWKH) for $6 million (CAD$8 million). Forfivo XL® (Bupropion extended-release)..
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.